Array BioPharma Inc. can head towards $7

90 0 0
Array seems to have found support and could break upwards the next weeks, based solely upon on the StochRSI and the weekly moving average trend. Besides that the fundamentals also look good. Analysts are bullish on this stock:

Array BioPharma Inc. (NASDAQ:ARRY) should head towards $11.08 per share according to 6 Analysts in consensus. The higher price estimate target is at $15 according to the Analysts.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.


Entry: 5.9 USD
Stop Loss: 5.5 USD
1. Target: 7.0 USD
2. Target: 7.75 USD

P.S. A screenshot of the daily chart with my trend lines from the weekly chart:

EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out